Tickerplace logo

Tickerplace

Pasithea Therapeutics Corp. logo

KTTAPasithea Therapeutics Corp.

KTTA Stock Price, Valuation & Chart | Pasithea Therapeutics Corp.

Compare
$0.580+0.02 (+3.07%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyKTTA intrinsic valueKTTA calculated fair value vs price
OverviewFinancialsDividendsRatios

KTTA Historical price chart

KTTA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization19.39M
PE Ratio-0.36
EPS-1.6
Trading Volume225.38K
Today's High/Low0.59/0.55
Dividend Yield0.00
52 Week High/Low2.06/0.28
Shares Outstanding33.41M
KTTA Financial Statement
KTTA Analyst ratings
KTTA Analysis & performance metrics

KTTA Company profile

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate…

KTTA Management team

Management
Lawrence Steinman BA, M.D., Ph.D.
Co-Founder, MD & Executive Chairman
Tiago Reis Marques M.D., Ph.D.CEO
Chief Executive Officer & Director
Daniel H. SchneidermanCFO
Chief Financial Officer
Total 3 executives

KTTA Frequently asked questions

What is Pasithea Therapeutics Corp. (KTTA) Stock Price?

Current stock price of Pasithea Therapeutics Corp. (KTTA) stock is $0.580. The stock price is +3.07% higher in the session. The intraday range can be seen from this page. Volume of Pasithea Therapeutics Corp. (KTTA) stock is 225.38K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Pasithea Therapeutics Corp. (KTTA) stock price going up or down today?

The stock price of Pasithea Therapeutics Corp. (KTTA) can change with earnings, company news, and overall market sentiment. Pasithea Therapeutics Corp. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Pasithea Therapeutics Corp. stock expensive at its current price?

Whether Pasithea Therapeutics Corp. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KTTA on this page is -0.36. EPS on this page is -1.60. Compare those figures with peers and growth expectations before deciding if the current Pasithea Therapeutics Corp. price is justified.

How has the stock price of Pasithea Therapeutics Corp. (KTTA) performed historically?

Historical performance for Pasithea Therapeutics Corp. (KTTA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KTTA reacted to past earnings and market events.

Should I buy Pasithea Therapeutics Corp. (KTTA) stock, at this price?

Buying Pasithea Therapeutics Corp. (KTTA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.